Dimebolin hydrochloride

盐酸地美波林

Report date: 2024/04/03 10:55:59
NME

Base Information

Drug NameDimebolin hydrochloride
Drug Alias NameLatrepirdine hydrochloride盐酸拉曲吡啶DimebonBRN-0622478PF-01913539 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptorAcetylcholinesterase
Therapy Area/IndicationsHypersensitivityDermatitis, AtopicAlzheimer Disease +[7] 
Global Approved IndicationsHypersensitivityDermatitis, AtopicRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date1983/01/01
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBigespas Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBigespas Ltd
Inactive CompaniesPfizer IncMedivation Inc
Active IndicationsHypersensitivityDermatitis, AtopicAlzheimer Disease +[5] 
Inactive IndicationsHuntington DiseaseLiver Failure

Other Information

ATC CodeR
Related LinksWikipediaDrugBankKEGG